TN2013000503A1 - Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia - Google Patents
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaInfo
- Publication number
- TN2013000503A1 TN2013000503A1 TNP2013000503A TN2013000503A TN2013000503A1 TN 2013000503 A1 TN2013000503 A1 TN 2013000503A1 TN P2013000503 A TNP2013000503 A TN P2013000503A TN 2013000503 A TN2013000503 A TN 2013000503A TN 2013000503 A1 TN2013000503 A1 TN 2013000503A1
- Authority
- TN
- Tunisia
- Prior art keywords
- treatment
- piperazino
- deuterated
- schizophrenia
- indanes
- Prior art date
Links
- QPABODDHXQJCDN-UHFFFAOYSA-N 1-(3-phenyl-2,3-dihydro-1h-inden-1-yl)piperazine Chemical class C12=CC=CC=C2C(C=2C=CC=CC=2)CC1N1CCNCC1 QPABODDHXQJCDN-UHFFFAOYSA-N 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 102000056834 5-HT2 Serotonin Receptors Human genes 0.000 abstract 1
- 108091005479 5-HT2 receptors Proteins 0.000 abstract 1
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161537103P | 2011-09-21 | 2011-09-21 | |
| PCT/IB2012/001386 WO2012176066A1 (fr) | 2011-06-20 | 2012-06-19 | 1-pipérazino-3-phénylindanes deutérés pour le traitement de la schizophrénie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000503A1 true TN2013000503A1 (en) | 2015-03-30 |
Family
ID=54359615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000503A TN2013000503A1 (en) | 2011-09-21 | 2013-12-03 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000503A1 (fr) |
-
2013
- 2013-12-03 TN TNP2013000503A patent/TN2013000503A1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX349754B (es) | Metodo para la administracion de 4-((1r,3s)-6-cloro-3-fenil-indan- 1-il)-1,2,2-trimetil-piperazina y de sus sales en el tratamiento de esquinozofrenia. | |
| IN2014DN09434A (fr) | ||
| PH12013502598A1 (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | |
| PH12015501404A1 (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
| MX2015016983A (es) | Moduladores del transporte nuclear y usos de los mismos. | |
| PH12014501967A1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| GB201111485D0 (en) | Drug composition and its use in therapy | |
| MX2014002395A (es) | Inhibidores de rock suaves, novedosos. | |
| TN2014000001A1 (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| PH12012502082A1 (en) | Combination of active loaded granules with additional actives | |
| PH12013501896A1 (en) | Use of a sprayable composition comprising ambroxol | |
| GB201115977D0 (en) | Neurodevelopmental disorders | |
| TN2013000503A1 (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | |
| MY166773A (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | |
| EP3064201A4 (fr) | Composition pharmaceutique pour prévenir et traiter des maladies du système nerveux central contenant de la fluoxétine et de la vitamine c en tant que substances actives | |
| GB201111427D0 (en) | Novel bisindolylmaleimides, pan-pkc inhibitors | |
| IN2013MU01239A (fr) |